REZNF (Street Capital) Moat Score: 2/10 (As of Jul. 01, 2026)


What is Street Capital Moat Score?

Street Capital REZNF Moat Score is 2 as of Jul. 01, 2026. Among 1,031 Drug Manufacturers companies, Street Capital ranks better than 81.67% on this metric.

Street Capital has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Street Capital has No Moat: Street Capital operates in a competitive financial services market with low barriers to entry and limited brand differentiation. The lack of significant cost advantages or proprietary technology results in a weak competitive position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Street Capital might have No Moat - Very weak/transient advantages.

Street Capital  (OTCPK:REZNF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Street Capital Moat Score Related Terms

REZNF vs CBSTQ, PNXP, GCAN: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Street Capital's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Street Capital Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Street Capital's Moat Score distribution charts can be found below:

* The bar in red indicates where Street Capital's Moat Score falls into.


Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Street Capital (REZNF) has a Moat Score of 2 as of Jul. 01, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Street Capital ranks #189 out of 1031 companies in the Drug Manufacturers industry, placing it in the top 18.3%.
Is Street Capital's Moat Score too high?
Street Capital's current Moat Score is 2. Based on the distribution chart, Street Capital ranks #189 out of 1031 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Street Capital's Moat Score compare to CBSTQ and PNXP?
According to the Drug Manufacturers industry distribution chart, Street Capital ranks #189 out of 1031 companies for Moat Score. This places Street Capital in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Street Capital's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Street Capital stock overvalued right now?
Street Capital (REZNF) has a current Moat Score of 2. The current Moat Score is 2. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Street Capital (REZNF), the current Moat Score is 2 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Street Capital Business Description

Address 1 Adelaide Street East, Suite 801, Toronto, ON, CAN, M5C 2V9
Street Capital Inc is inactive.